Pharmacogenomics in the Workplace: A New Frontier for Employee Wellness Programs

Did you know 82% of U.S. adults take at least one prescription drug? Even more surprising, 1 in 4 rely on five or more medications daily. This heavy reliance on prescriptions creates risks—like adverse reactions or ineffective treatments—costing employers billions yearly.
Forward-thinking companies now integrate DNA-based testing into wellness initiatives. These programs analyze how genes affect medication responses, reducing errors and improving health outcomes. One study showed a $128 monthly savings per employee by optimizing prescriptions.
With over 340 FDA-approved drugs linked to genetic factors, personalized approaches are reshaping healthcare. Instead of guessing which treatments work, employers use data to prevent complications before they start. The result? Fewer sick days, lower costs, and healthier teams.

Why Pharmacogenomics in the Workplace is the Next Big Thing in Corporate Wellness
U.S. companies lose $528 billion yearl...